文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

限制性液体治疗对感染性休克ICU患者高乳酸血症缓解时间的影响:CLASSIC随机试验的次要事后分析

Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial.
PubMed 文献 · Intensive Care Med · 2024-04-10
一句话结论在感染性休克成人ICU患者中,限制性静脉液体策略似乎不影响高乳酸血症的缓解时间(校正后与未校正结果一致)。

本研究为国际多中心CLASSIC随机试验的事后分析,纳入777例成人ICU感染性休克患者,随机接受限制性(n=385)或标准(n=392)静脉液体治疗,旨在评估限制性液体对高乳酸血症缓解时间的影响。采用竞争风险回归模型分析,死亡和出院为竞争结局,随机化后72小时若高乳酸血症持续则进行行政删失。结果显示,限制性组与标准组相比,第1天缓解的累积概率HR为0.94(95%CI 0.78-1.14),第2-3天HR为1.21(95%CI 0.89-1.65),校正分析与未校正结果一致。作者认为,限制性静脉液体策略似乎未影响高乳酸血症的缓解时间。

要点

  • 在感染性休克成人ICU患者中,限制性静脉液体策略与标准策略相比,高乳酸血症缓解时间无显著差异。
  • 第1天高乳酸血症缓解的累积概率HR为0.94(95%CI 0.78-1.14),第2-3天HR为1.21(95%CI 0.89-1.65)。
  • 校正分析结果与未校正分析一致,支持限制性液体策略不延长高乳酸血症持续时间。
  • 该研究为CLASSIC试验的事后分析,样本量777例,结果需结合原试验主要终点解读。

适用人群与场景

  • 国际多中心CLASSIC试验中纳入的成人ICU感染性休克患者,共777例,其中限制性液体组385例,标准液体组392例。

研究设计与关键结果

  • 研究类型:国际多中心随机对照试验(CLASSIC)的次要事后分析。
  • 人群:成人ICU感染性休克患者,随机分为限制性静脉液体组(n=385)和标准静脉液体组(n=392)。
  • 主要终点:高乳酸血症缓解时间,采用竞争风险回归模型分析,死亡和出院为竞争结局,随机化后72小时若高乳酸血症持续则行政删失。
  • 未校正分析:限制性组 vs 标准组第1天缓解的累积概率HR为0.94(95%CI 0.78-1.14),第2-3天HR为1.21(95%CI 0.89-1.65)。
  • 校正分析结果与未校正分析一致。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在成人ICU感染性休克患者中,限制性静脉液体策略似乎不影响高乳酸血症的缓解时间。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to examine the effects of intravenous (IV) fluid restriction on time to resolution of hyperlactatemia in septic shock. Hyperlactatemia in sepsis is associated with worse outcome. Sepsis guidelines suggest targeting lactate clearance to guide fluid therapy despite the complexity of hyperlactatemia and the potential harm of fluid overload.

METHODS: We conducted a post hoc analysis of serial plasma lactate concentrations in a sub-cohort of 777 patients from the international multicenter clinical CLASSIC trial (restriction of intravenous fluids in intensive care unit (ICU) patients with septic shock). Adult ICU patients with septic shock had been randomized to restrictive (n = 385) or standard (n = 392) intravenous fluid therapy. The primary outcome, time to resolution of hyperlactatemia, was analyzed with a competing-risks regression model. Death and discharge were competing outcomes, and administrative censoring was imposed 72 h after randomization if hyperlactatemia persisted. The regression analysis was adjusted for the same stratification variables and covariates as in the original CLASSIC trial analysis.

RESULTS: The hazard ratios (HRs) for the cumulative probability of resolution of hyperlactatemia, in the restrictive vs the standard group, in the unadjusted analysis, with time split, were 0.94 (confidence interval (CI) 0.78-1.14) at day 1 and 1.21 (0.89-1.65) at day 2-3. The adjusted analyses were consistent with the unadjusted results.

CONCLUSION: In this post hoc retrospective analysis of a multicenter randomized controlled trial (RCT), a restrictive intravenous fluid strategy did not seem to affect the time to resolution of hyperlactatemia in adult ICU patients with septic shock.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ahlstedt C, Sivapalan P, Kriz M, et al. Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial. Intensive Care Med. 2024. PMID: 38598125. doi:10.1007/s00134-024-07385-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。